Hillsdale Investment Management Inc. Agios Pharmaceuticals, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 200 shares of AGIO stock, worth $6,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$6,484
Previous $8,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
233Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$184 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$180 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$158 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$121 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$91.8 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.78B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...